Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Clinician Scientist - Phase 2

University of Alberta

$180,000.00

Targeting the cardiac troponin complex to enhance the understanding, diagnosis, and treatment of heart disease

FY 2016-17

Summary
In heart muscle cells, the protein troponin complex is the molecular switch that turns contraction on and off with each heartbeat. Troponin is important to the health of Canadians in the following ways: 1) Genetic diseases are caused by DNA mutations that change the structure of a particular protein. The heritable cardiomyopathies are common genetic disorders (about 1:500) affecting heart muscle proteins like troponin, increasing the risk of heart failure and sudden cardiac death. We are studying how the function of troponin is regulated in the healthy heart, and how it becomes dysregulated by mutations. This will allow us to develop drugs to correct the problem. 2) We are designing troponin-specific drugs to correct the effect of mutations that cause the heritable cardiomyopathies. This would improve heart muscle function and restore normal muscle growth, preventing the development of heart failure. We anticipate that these drugs could also be used to treat heart failure caused by other conditions. 3) When the heart is damaged, troponin leaks into the bloodstream, where it can be detected by blood tests used by physicians to diagnose heart damage. In a heart attack, not only is troponin released, but it is also partially digested by enzymes. Right now, conventional blood tests do not distinguish between intact troponin and digested troponin. We are developing a blood test to make this distinction, which will provide more useful information about the cause of heart damage in order to guide treatment. Understanding troponin will help doctors to better diagnose and treat heart disease, which affect over a million Canadians every year.
Program
CIHR Clinician Scientist - Phase 2
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
359460
Name
Hwang Peter
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
Targeting the cardiac troponin complex to enhance the understanding, diagnosis, and treatment of heart disease
Programtype2
Salary Programs
Orgnameinp2
University of Alberta
Cihramount2
$180,000
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 2
Keyworddelim
Diagnostic Test Development; Drug Development; Heritable Cardiomyopathies; Myocardial Infarction; Nmr Spectroscopy; Protein Function; Protein Structure
Abstract
In heart muscle cells, the protein troponin complex is the molecular switch that turns contraction on and off with each heartbeat. Troponin is important to the health of Canadians in the following ways: 1) Genetic diseases are caused by DNA mutations that change the structure of a particular protein. The heritable cardiomyopathies are common genetic disorders (about 1:500) affecting heart muscle proteins like troponin, increasing the risk of heart failure and sudden cardiac death. We are studying how the function of troponin is regulated in the healthy heart, and how it becomes dysregulated by mutations. This will allow us to develop drugs to correct the problem. 2) We are designing troponin-specific drugs to correct the effect of mutations that cause the heritable cardiomyopathies. This would improve heart muscle function and restore normal muscle growth, preventing the development of heart failure. We anticipate that these drugs could also be used to treat heart failure caused by other conditions. 3) When the heart is damaged, troponin leaks into the bloodstream, where it can be detected by blood tests used by physicians to diagnose heart damage. In a heart attack, not only is troponin released, but it is also partially digested by enzymes. Right now, conventional blood tests do not distinguish between intact troponin and digested troponin. We are developing a blood test to make this distinction, which will provide more useful information about the cause of heart damage in order to guide treatment. Understanding troponin will help doctors to better diagnose and treat heart disease, which affect over a million Canadians every year.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hwang, Peter
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $180,000~ $0~
University of Alberta - $180,000 Grant (2016-17) | Canada Spends